Cargando…

Propriété industrielle et recherche fondamentale dans la genèse du vaccin ARNm contre la COVID-19()

The extreme speed of the design and provisional approval of the covid-19 mRNA vaccines, as well as the speed of their mass production one year after the start of the pandemic, surprised and contradicted all the experts and big pharmaceutical companies who expected years of development. Their superio...

Descripción completa

Detalles Bibliográficos
Autor principal: Migus, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558088/
https://www.ncbi.nlm.nih.gov/pubmed/36267560
http://dx.doi.org/10.1016/j.banm.2022.06.014